Showing 621-630 of 9096 results for "".
Hoya ConBio - Operation of the Medlite C6
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/hoya-conbio-operation-of-the-medlite-c6/19458/Operation of the Medlite C6 laser for skin renewal is demonstrated.Spectra Laser Toning for Melasma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/laser-toning/19525/The Spectra Laser VRM Q-switche Nd:YAG laser used to treat melasma.Practical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases, Ch. 4
https://practicaldermatology.com/programs/practical-dermatology/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-4/56872/In the fourth installment of this eight-part series, host Ted Lain, MD, MBA, FAAD, and guests Zoe Diana Draelos, MD, and Firas George Hougeir, MD, FAAD, focus on how adjuvant skincare may influence treatment pathways, including delaying or optimizing escalation to systemic therapies.1 Draelos Z, HoA Closer Look at OX40 Pathway Modulation
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/a-closer-look-at-ox40-pathway-modulation/50890/Walter Liszewski, MD, talks with Matthew Zirwas, MD, about the potential therapeutic applications, based on the article “Targeting the OX40-OX40L pathway: A new era in atopic dermatitis management by T-cell rebalancing,”1 as well as the risks of therapies targeting the OX40 pathway.PDRN and Regenerative Medicine Update
https://practicaldermatology.com/conferences/science-of-skin-summit-2025/pdrn-regenerative-medicine-update/39739/Suneel Chilukuri, MD, covers the latest in polydeoxyribonucleotide (PDRN) therapies and regenerative medicine applications in dermatology. This video was recorded at the Science of Skin Summit in Austin, TX.DermwireTV: FDA Clears Roflumilast, Guselkumab for Pediatric Populations, Plus More
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-fda-clears-roflumilast-guselkumab-for-pediatric-populations-plus-more/39732/This episode highlights two new important pediatric approvals for treatments in both atopic dermatitis and psoriatic disease, also features a clip from a recent YoungMD Connect (YMDC) mentorship session with Dr. Tina Bhutani covering both career paths in both academia and industry.Psoriasis Therapeutics and Moving to Private Practice
https://practicaldermatology.com/podcasts/practical-dermatology-podcasts/program-name/35733/H.L. Greenberg, MD, discusses his recent Practical Dermatology article on the various benefits of different psoriasis therapeutics, and Tina Bhutani, MD, MAS, FAAD, joins Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, to discuss the transition from academia to private practice and playMasterclasses in Dermatology: Updates on Vasculitis
https://practicaldermatology.com/programs/practical-dermatology/masterclasses-in-dermatology-updates-on-vasculitis/33018/Scott Elman, MD, a double board-certified internist and dermatologist at the University of Miami, outlines his talks at Masterclasses in Dermatology on the latest updates on vasculitis and on the importance of diagnosing dermatomyositis.- Risk Stratification Testing for Melanomahttps://practicaldermatology.com/videos/c-suite-chats/risk-stratification-testing-for-melanoma/32838/Derek Maetzold, president and CEO of Castle Biosciences, discusses the importance of personalized management and treatment approaches for patients diagnosed with melanoma, and how gene expression profile testing can help.
Leading Dermatologists Summarize Maui Derm Presentations
https://practicaldermatology.com/videos/dermwire-tv/leading-dermatologists-summarize-maui-derm-presentations/32839/In this week's DermwireTV, top thought leaders provide a summary of their presentations at Maui Derm; a new analysis examines a link between hidradenitis suppurativa genetics and coronary artery disease risk; and the president of Castle Biosciences joins us for this week's C-Suite Chats f